Business Context and Reporting Period
This Form 8-K is a current report filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on August 20, 2014. The filing serves as a Regulation FD disclosure to disseminate a letter from CEO Kimble Jenkins to stockholders, which is attached as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a procedural filing to distribute a letter to shareholders and does not contain a financial statement or performance data within the main body of the report.
Material Changes
No material financial changes or operational updates are detailed in the text of this filing. The report solely references the issuance of a letter to stockholders.
Guidance, Outlook, and Risks
The filing explicitly states that the information contained in the attached letter (Exhibit 99.1) is summary information and should be considered in the context of other SEC filings and public announcements. The Company undertakes no duty or obligation to publicly update or revise the information contained in this report, although it may do so as management believes is warranted. No specific guidance, outlook, or risk factors are enumerated in the text of this 8-K.
Investor Verification Checklist
- Verify the content of the August 20, 2014 letter from CEO Kimble Jenkins (Exhibit 99.1), as the substantive communication is not included in the main text of this filing.
- Confirm the registrant name is MRI Interventions, Inc., noting the discrepancy with the "Clearpoint Neuro, Inc." metadata provided in the request.
- Review the Company's website (http://ir.stockpr.com/mriinterventions/company-news) for the posted letter and any subsequent updates.
- Check prior SEC filings for the most recent audited financial statements, as this 8-K does not contain financial data.